Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. - Wikidata - awgldk - TriplyDB

Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

http://www.wikidata.org/entity/Q34183875

about

Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features Towards medication-enhancement of cognitive interventions in schizophrenia Modeling psychiatric disorders at the cellular and network levels Are we studying and treating schizophrenia correctly?Contribution of nonprimate animal models in understanding the etiology of schizophrenia.Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.Dynamic expression of tyrosine hydroxylase mRNA and protein in neurons of the striatum and amygdala of mice, and experimental evidence of their multiple embryonic origin.The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity.The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia.Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings.Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.Pathway-Specific Dopamine Abnormalities in Schizophrenia.Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders.Neuroimaging in psychiatric disorders The applicability of SRTM in [(18)F]fallypride PET investigations: impact of scan durations.Investigation of anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia.18F-fallypride binding potential in patients with schizophrenia compared to healthy controls Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone.Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.Response to Deep Brain Stimulation in Three Brain Targets with Implications in Mental Disorders: A PET Study in Rats Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task Neurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study Timing of moderate level prenatal alcohol exposure influences gene expression of sensory processing behavior in rhesus monkeys.Basal ganglia pathology in schizophrenia: dopamine connections and anomalies.A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia.Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.How have developments in molecular imaging techniques furthered schizophrenia research?Positron emission tomography in psychiatric disorders.Abnormal striatal dopamine transmission in schizophrenia Pluripotent stem cells in neuropsychiatric disorders.The computational anatomy of psychosis.

P2860

Q21136367-00C9DE22-5411-4CA6-95D4-0DA0550AFF1C Q24630410-30F9F74D-F9CC-445A-B0BE-603E126589E1 Q26860777-DB1740CA-FF04-4EAE-900D-CACF8D833CD7 Q30446669-7B9059EE-C4CE-4E5A-B564-6744204AB856 Q30465313-CBB8DBEE-1783-4EF9-94BA-02261DB283AB Q30474963-0B8C9BA7-F33E-48E3-81BB-0E466C8BE629 Q30854782-E3D9E73D-48D5-4365-B62C-444850210B95 Q31108616-C7172E4C-29B0-4F6E-A598-A33DAF8A0065 Q33620303-10944DBB-939C-4E6A-8AA8-E0DC667E3320 Q33635632-FC71EE18-6E45-42C4-A426-4ADD0BB3C0E4 Q33680372-69DAFD70-7C4D-4A46-8AB2-2C031B304A7E Q33821967-A4DAAEFB-5A66-4316-B8C6-3956B4D8CF37 Q33893744-D8FCF9B7-82D5-4BC0-A1B7-BC2AA4F32F9F Q34051160-4BE4F7FA-D1E3-4EEF-B9A3-B4B4CE36A436 Q34079702-FD8F5E51-8E8E-453C-8FCF-A1778B9170C0 Q34187457-605ED7B1-4999-4F24-B581-34980365D6B1 Q34490087-280127D1-839D-4605-9C0C-5F2B2650E5BD Q34527656-2DC0C603-0CEF-4FCB-B40C-27C1AB4D4D76 Q34608239-B4E15B18-F0E8-4BCA-822B-AFC95AAC378D Q34644697-1AB98D9A-3523-492B-9BCF-1C831BC1C1DE Q35262159-A61F1C08-ADF9-4139-AD83-FE486BCFE55F Q35622657-EC3D0D99-DBEA-4CEB-831A-B4ACF3422687 Q35752862-407C8CA6-6DF9-4A1F-AD2F-4CFB2580791E Q35847706-76AA1B12-4226-4311-BC87-56BE2C2B467E Q35898332-45684291-0515-4777-95FD-6AEE185D4D0C Q35950793-F72AE751-D16E-4311-A6C6-C11BF96066C7 Q36235617-90948984-2DE9-4567-98B0-60F5B987CDAB Q36636329-78DF08DD-DDEB-4A22-8328-85AAF05FB57F Q37009643-E525B0E4-CA39-4ECA-99F3-DD22B867BE12 Q37141400-016F72C3-D8CA-4FB0-91CE-E08B5ED7A954 Q37256211-5040CAC5-7F9A-4EF1-AE49-B62E73ACE140 Q37425295-4C83E1DE-6BE5-4880-8102-4DFDEE3EF9FC Q37678649-E07A979A-F607-4455-BDBC-8A05936AC135 Q37765676-5A6D8BD5-D56C-46F0-AB27-3ECA9B2A448E Q37825633-9D33A896-809D-440D-94BD-96C80EAD3920 Q37829639-FEB280B6-2C1D-44F9-A1C1-759977EA44F3 Q37975237-0523C694-A6AF-4863-A049-472F03F879AF Q38060250-811585E0-FD79-42B2-8269-543FB83CD71E Q39189500-E05ED99D-AFBC-4144-AB49-BF3880247063 Q41199035-C8360BF2-6C10-4EB7-B294-A2C63BF6B4DE

P2860

Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects.

http://www.wikidata.org/entity/Q34183875

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@ast

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@en

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@nl

type

label

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@ast

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@en

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@nl

prefLabel

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@ast

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@en

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@nl

P1433

Q34183875-D72A6BD8-D860-4A79-A5B0-B0D9C0E36709

P1476

Q34183875-DE631B07-D6B2-457B-B70E-514FD23A7D76

P2093

Q34183875-26AD11AA-BD5A-4835-AD77-C290E8E1CFFF

Q34183875-2ECCF9DC-3455-4B19-847B-1FF6EB4697F7

Q34183875-443205CA-3267-4304-9C46-AB363D9B1ECE

Q34183875-62776B00-6B70-4640-8D7A-036227B4E914

Q34183875-761D9673-3BFB-4344-91C5-802D925DCA86

Q34183875-AD1F2B2A-ACC4-4270-A7AE-BFB96A05D3B4

Q34183875-C6480103-EB66-48EB-8033-8F193BA59960

Q34183875-DD930391-620F-4B4A-83A7-23888F68712B

Q34183875-F72E35E3-A11C-4DD2-BF10-717D4E8FE9AA

P2860

Q34183875-03F77C9E-9329-442C-9E15-DBCB6B7D093B

Q34183875-05432C2F-59C1-4690-9E8F-E5E1FD68E4AC

Q34183875-056D0060-80FF-47A8-90AF-C9D5012E1CE2

Q34183875-0603E850-6344-4F9D-AAB2-34BCCDFF9200

Q34183875-06744065-475C-4003-9B0D-F15528A30F6C

Q34183875-071EF26D-7DB0-4E1C-B3F5-1C8728F266F2

Q34183875-0AD0B357-5B8B-48BA-B6FB-B845E698F56C

Q34183875-0C250F0D-BF66-4AD7-98EA-14F00BAEC7CA

Q34183875-0CB2B812-32CB-45FD-910D-E44C7648255D

Q34183875-11173847-B4B9-47D8-9D31-DDDB2093991E

P304

Q34183875-865E2013-BF29-4A2A-B1EC-55BD395E50C8

P31

Q34183875-8F55962F-300E-4301-97FD-BB8381AD39D4

P356

Q34183875-E2C94AA9-3137-4616-BCFE-0AFBAAD204D3

P407

Q34183875-6755527B-E4FA-4A8D-9046-4145C64FC64D

P433

Q34183875-A5503CEC-C9DF-4490-A008-EB947793CE14

P478

Q34183875-2F09979A-E418-4873-84D1-2FB995CD99A0

P577

Q34183875-55CDA4D4-9DA0-4132-9692-94438404B811

P5875

Q34183875-E63D1CC4-4A41-4990-BCF7-A38A0374435C

P698

Q34183875-4BF24BBC-F829-4970-91AA-A56C9F012FFB

P921

Q34183875-477ECCC7-648D-4E1F-9178-9CDF1C906342

Q34183875-5013E9EE-B434-4266-A5E9-D5D18928E6E0

Q34183875-7192EE97-AE3C-457C-8F96-3AD57A550F50

Q34183875-e1c75fc9-d7b8-4b56-bf2a-f086e73f4a0f

P932

Q34183875-D8E4CACB-A739-4025-8EB6-43F240CA2A95

P356

J.BIOPSYCH.2008.12.029

P1433

Biological Psychiatry

P1476

Dopamine D2 receptor levels in ...... tex in schizophrenic subjects.

@en

P2093

Benoit Dawant

http://www.w3.org/2001/XMLSchema#string

David Zald

http://www.w3.org/2001/XMLSchema#string

Herbert Y Meltzer

http://www.w3.org/2001/XMLSchema#string

M Sib Ansari

http://www.w3.org/2001/XMLSchema#string

Neil D Woodward

http://www.w3.org/2001/XMLSchema#string

Patrizia Riccardi

http://www.w3.org/2001/XMLSchema#string

Robert M Kessler

http://www.w3.org/2001/XMLSchema#string

Rui Li

http://www.w3.org/2001/XMLSchema#string

Sharlett Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

Cortical inhibitory neurons and schizophrenia

Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold

Prefrontal neurons and the genetics of schizophrenia.

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia.

Increased dopamine transmission in schizophrenia: relationship to illness phases.

Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.

Analysis of emission tomographic scan data: limitations imposed by resolution and background.

Distribution of dopamine D2-like receptors in the human thalamus: autoradiographic and PET studies.

P304

1024-1031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2008.12.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24145786

http://www.w3.org/2001/XMLSchema#string

P698

19251247

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum

substantia nigra

P932

2951678

http://www.w3.org/2001/XMLSchema#string